Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
July 31, 2023
Consolidated Financial Results | |
for the Three Months Ended June 30, 2023 | |
(Under Japanese GAAP) | |
Company name: Taoka Chemical Co., Ltd | |
Listing: | Tokyo Stock Exchange |
Securities code: | 4113 |
URL: | https://www.taoka-chem.co.jp |
Representative: | Yasuaki Sasaki, President |
Inquiries: | Yasuhito Katsumoto, General Manager, Business Services Office |
Telephone: | +81-6-7639-7400 |
Scheduled date to file quarterly securities report: | August 9, 2023 |
Scheduled date to commence dividend payments: | - |
Preparation of supplementary material on quarterly financial results: None | |
Holding of quarterly financial results briefing: | None |
(Yen amounts are rounded down to millions, unless otherwise noted.)
1. Consolidated financial results for the three months ended June 30, 2023 (from April 1, 2023 to June 30, 2023)
(1) Consolidated operating results (cumulative) | (Percentages indicate year-on-year changes.) | ||||||||
Net income | |||||||||
Sales revenue | Operating income | Ordinary income | attributable to | ||||||
owners of the | |||||||||
parent | |||||||||
Three months ended | Millions of | % | Millions of | % | Millions of | % | Millions of | % | |
yen | yen | yen | yen | ||||||
June 30, 2023 | 7,426 | (8.8) | 2 | (98.6) | 29 | (87.1) | 27 | (78.9) | |
June 30, 2022 | 8,140 | (8.7) | 203 | (75.2) | 225 | (73.1) | 131 | (78.2) |
Note: Comprehensive income | For the three months ended June 30, 2023: ¥54 million [(66.0)%] | |||
For the three months ended June 30, 2022: ¥159 million [(73.4)%] | ||||
Net income | Diluted net income | |||
per share | per share | |||
Three months ended | Yen | Yen | ||
June 30, 2023 | 1.94 | - | ||
June 30, 2022 | 9.20 | - | ||
(2) Consolidated financial position | ||||
Total assets | Net assets | Equity-to-asset | ||
ratio | ||||
As of | Millions of yen | Millions of yen | % | |
June 30, 2023 | 30,389 | 16,496 | 54.3 | |
March 31, 2023 | 31,069 | 16,570 | 53.3 |
Reference: Equity | |||||||||
As of June 30, 2023: | ¥16,496 million | ||||||||
As of March 31, 2023: | ¥16,570 million | ||||||||
2. Cash dividends | |||||||||
Annual dividends per share | |||||||||
First | Second | Third | Fiscal year- | Total | |||||
quarter-end | quarter-end | quarter-end | end | ||||||
Yen | Yen | Yen | Yen | Yen | |||||
Fiscal year ended | - | 18.00 | - | 9.00 | 27.00 | ||||
March 31, 2023 | |||||||||
Fiscal year ending | - | ||||||||
March 31, 2024 | |||||||||
Fiscal year ending | |||||||||
March 31, 2024 | 9.00 | - | 9.00 | 18.00 | |||||
(Forecast) | |||||||||
Note: Revisions to the forecasts of cash dividends most recently announced: None
3. Consolidated financial forecasts for the fiscal year ending March 31, 2024 (from April 1, 2023 to March 31, 2024)
(Percentages indicate year-on-year changes.)
Net income | Net | |||||||||
attributable to | ||||||||||
Sales revenue | Operating income | Ordinary income | income | |||||||
owners of the | ||||||||||
per share | ||||||||||
parent | ||||||||||
Millions of | % | Millions of | % | Millions of | % | Millions of | % | yen | ||
yen | yen | yen | yen | |||||||
Second | 15,000 | (1.7) | 150 | (39.8) | 150 | (46.3) | 100 | (47.7) | 6.98 | |
quarter-end | ||||||||||
(Cumulative) | ||||||||||
Full year | 32,000 | 6.1 | 700 | 55.2 | 700 | 52.9 | 400 | 28.8 | 27.92 |
Note: Revisions to the forecasts of consolidated financial results most recently announced: None
* Notes
- Changes in significant subsidiaries during the period (changes in specified subsidiaries resulting in the change in scope of consolidation): None
- Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements: Yes
- Changes in accounting policies, changes in accounting estimates, and restatement
- Changes in accounting policies due to revisions to accounting standards and other regulations: None
- Changes in accounting policies due to other reasons: None
- Changes in accounting estimates: None
- Restatement: None
- Number of issued shares (common shares)
- Total number of issued shares at the end of the period (including treasury shares)
As of June 30, 2023
As of March 31, 2023
14,440,000 shares
14,440,000 shares
(ii) Number of treasury shares at the end of the period
As of June 30, 2023
As of March 31, 2023
111,140 shares
111,140 shares
- Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)
Three months ended June 30, 2023
Three months ended June 30, 2022
14,328,860 shares
14,328,860 shares
- Quarterly financial results reports are exempt from quarterly review conducted by certified public accountants or an audit corporation.
-
Proper use of earnings forecasts, and other special matters (Caution regarding forward-looking statements and others)
The forward-looking statements, including financial forecasts, contained in this report are based on information currently available to the Company and certain assumptions deemed to be reasonable. Accordingly, they are not intended to be construed as assurance that they will be accomplished in the future. Note that actual results may differ materially from the forecasts for a number of reasons.
The Taoka Chemical Group's consolidated sales revenue for the three months ended June 30, 2023, decreased by ¥ 713 million compared with the same period of the previous fiscal year, to ¥7,426 million. The Group posted operating income of ¥ 2 million, ordinary income of ¥ 29 million and net income attributable to owners of the parent of ¥ 27 million.
The financial results of Taoka Chemical by business segment for the three month period were as follows:
Division | Three Months Ended Three Months Ended | Change | |||||
June 30, 2022 | June 30, 2023 | ||||||
Millions of Composition Millions of Composition Millions of | Year-on-year | ||||||
yen | ratio (%) | yen | ratio (%) | yen | rate (%) | ||
Fine Chemicals | 4,199 | 51.6 | 3,616 | 48.7 | (583) | (13.9) | |
Functional Chemicals | 827 | 10.2 | 859 | 11.6 | 32 | 3.9 | |
Functional Polymers and | 2,971 | 36.5 | 2,814 | 37.9 | (156) | (5.3) | |
Additives | |||||||
Chemicals Segment | 7,997 | 98.3 | 7,290 | 98.2 | (707) | (8.8) | |
Analytical Services | 142 | 1.7 | 136 | 1.8 | (6) | (4.3) | |
Total | 8,140 | 100.0 | 7,426 | 100.0 | (713) | (8.8) |
Note: The "Analytical Services," which previously composed the "Others" segment, has been presented as a reportable segment because its quantitative importance has increased.
Chemicals Segment
Sales revenue of this segment was ¥7,290 million, a ¥707 million decrease compared to the same period of the previous fiscal year.
Fine Chemicals Division
Though shipments of agrochemical intermediates increased, shipments of monomers for optical resins decreased. As a result, the division sales revenue decreased by ¥583 million, to ¥3,616 million.
Functional Chemicals Division
A decrease in sales revenue due to a decrease in shipments of rubber additives was outweighed by an increase in sales revenue due to an increase in shipments of adhesives. As a result, the division sales revenue increased by ¥32 million to ¥859 million.
Functional Polymers and Additives Division
Shipments of plasticizers, paper chemicals and varnish decreased. As a result, the division sales revenue decreased by ¥156 million, to ¥2,814 million.
Analytical Services Segment
Sales of asbestos analysis and composition and structural analysis decreased. As a result, the segment sales revenue decreased by ¥6 million, to ¥136 million.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Taoka Chemical Co. Ltd. published this content on 31 July 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 July 2023 07:40:11 UTC.